Bausch Health Companies Stock Buy Hold or Sell Recommendation
| BHC Stock | USD 7.15 0.26 3.77% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Bausch Health Companies is 'Cautious Hold'. Macroaxis provides Bausch Health buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BHC positions.
Check out Bausch Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Bausch and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Bausch |
Execute Bausch Health Buy or Sell Advice
The Bausch recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bausch Health Companies. Macroaxis does not own or have any residual interests in Bausch Health Companies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bausch Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Bausch Health Trading Alerts and Improvement Suggestions
| Bausch Health generated a negative expected return over the last 90 days | |
| The company reported the last year's revenue of 9.52 B. Reported Net Loss for the year was (72 M) with profit before taxes, overhead, and interest of 6.84 B. | |
| Bausch Health has a strong financial position based on the latest SEC filings | |
| About 71.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Bausch Health Companies Announces Next Steps In Financing Initiative With J.P. Morgan - Marketscreener.com |
Bausch Health Returns Distribution Density
The distribution of Bausch Health's historical returns is an attempt to chart the uncertainty of Bausch Health's future price movements. The chart of the probability distribution of Bausch Health daily returns describes the distribution of returns around its average expected value. We use Bausch Health Companies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bausch Health returns is essential to provide solid investment advice for Bausch Health.
| Mean Return | -0.15 | Value At Risk | -4.43 | Potential Upside | 3.80 | Standard Deviation | 3.01 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bausch Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bausch Stock Institutional Investors
| Shares | Franklin Resources Inc | 2024-12-31 | 5.3 M | Maple Rock Capital Partners, Inc. | 2024-12-31 | 5.3 M | Kohlberg Kravis Roberts & Co Lp | 2024-12-31 | 5.2 M | Citadel Advisors Llc | 2024-12-31 | 5.2 M | Arrowstreet Capital Limited Partnership | 2024-12-31 | 4.8 M | Sg Americas Securities, Llc | 2024-12-31 | 3.3 M | Dimensional Fund Advisors, Inc. | 2024-12-31 | 3.1 M | Bnp Paribas Arbitrage, Sa | 2024-12-31 | 3 M | Laurion Capital Management Lp | 2024-12-31 | 2.7 M | Icahn Carl C | 2024-12-31 | 34.7 M | Goldentree Asset Management Lp | 2024-12-31 | 27.5 M |
Bausch Health Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (77M) | (16M) | (198M) | (322M) | (267M) | (253.7M) | |
| Change In Cash | (1.4B) | 303M | (1.5B) | 371M | 239M | 251.0M | |
| Free Cash Flow | 802M | 1.1B | (996M) | 760M | 1.3B | 1.3B | |
| Depreciation | 1.8B | 1.6B | 1.4B | 1.3B | 1.3B | 941.3M | |
| Other Non Cash Items | 581M | 1.0B | (1.5B) | 778M | 179M | 170.1M | |
| Capital Expenditures | 309M | 283M | 268M | 272M | 337M | 176.6M | |
| Net Income | (559M) | (937M) | (212M) | (611M) | (72M) | (75.6M) | |
| End Period Cash Flow | 1.8B | 2.1B | 591M | 962M | 1.2B | 626.9M | |
| Change To Netincome | 1.4B | (376M) | (189M) | (2.5B) | (2.2B) | (2.1B) | |
| Investments | 4M | (4M) | 5M | (2.1B) | (454M) | (431.3M) | |
| Change Receivables | 39M | 170M | (229M) | (57M) | (65.6M) | (68.8M) | |
| Net Borrowings | 1.5B | (2.2B) | (1.4B) | (1.1B) | (972.9M) | (924.3M) |
Bausch Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bausch Health or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bausch Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bausch stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.15 | |
β | Beta against Dow Jones | 0.16 | |
σ | Overall volatility | 2.86 | |
Ir | Information ratio | -0.02 |
Bausch Health Volatility Alert
Bausch Health Companies exhibits very low volatility with skewness of -0.43 and kurtosis of 4.13. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bausch Health's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bausch Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bausch Health Implied Volatility
Bausch Health's implied volatility exposes the market's sentiment of Bausch Health Companies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bausch Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bausch Health stock will not fluctuate a lot when Bausch Health's options are near their expiration.
Bausch Health Fundamentals Vs Peers
Comparing Bausch Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bausch Health's direct or indirect competition across all of the common fundamentals between Bausch Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bausch Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bausch Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bausch Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bausch Health to competition |
| Fundamentals | Bausch Health | Peer Average |
| Return On Equity | -23.05 | -0.31 |
| Return On Asset | 0.0433 | -0.14 |
| Profit Margin | (0) % | (1.27) % |
| Operating Margin | 0.23 % | (5.51) % |
| Current Valuation | 23.07 B | 16.62 B |
| Shares Outstanding | 367.93 M | 571.82 M |
| Shares Owned By Insiders | 11.31 % | 10.09 % |
| Shares Owned By Institutions | 70.94 % | 39.21 % |
| Number Of Shares Shorted | 6.45 M | 4.71 M |
| Price To Earning | 9.26 X | 28.72 X |
| Price To Book | 18.78 X | 9.51 X |
| Price To Sales | 0.28 X | 11.42 X |
| Revenue | 9.52 B | 9.43 B |
| Gross Profit | 6.84 B | 27.38 B |
| EBITDA | 1.55 B | 3.9 B |
| Net Income | (72 M) | 570.98 M |
| Cash And Equivalents | 564 M | 2.7 B |
| Cash Per Share | 1.34 X | 5.01 X |
| Total Debt | 2.67 B | 5.32 B |
| Current Ratio | 1.05 X | 2.16 X |
| Book Value Per Share | (3.48) X | 1.93 K |
| Cash Flow From Operations | 1.6 B | 971.22 M |
| Short Ratio | 2.06 X | 4.00 X |
| Earnings Per Share | (0.13) X | 3.12 X |
| Price To Earnings To Growth | 0.63 X | 4.89 X |
| Target Price | 8.67 | |
| Number Of Employees | 20.7 K | 18.84 K |
| Beta | 0.6 | -0.15 |
| Market Capitalization | 2.65 B | 19.03 B |
| Total Asset | 26.52 B | 29.47 B |
| Retained Earnings | (9.82 B) | 9.33 B |
| Working Capital | (978 M) | 1.48 B |
| Current Asset | 984.02 M | 9.34 B |
Note: Acquisition by Charhon Jean-jacques of 216622 shares of Bausch Health subject to Rule 16b-3 [view details]
Bausch Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bausch . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bausch Health Buy or Sell Advice
When is the right time to buy or sell Bausch Health Companies? Buying financial instruments such as Bausch Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bausch Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run High Dividend Yield ETFs Thematic Idea Now
High Dividend Yield ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The High Dividend Yield ETFs theme has 114 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize High Dividend Yield ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bausch Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share (0.13) | Revenue Per Share | Quarterly Revenue Growth 0.063 | Return On Assets |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.